TBP Survey Among Respiratory Physicians

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 26, 2024

Keywords

ClinConnect Summary

This is an international online survey of respiratory doctors in the Asia-Pacific region to understand how tuberculous pleural effusion (TBP) is diagnosed and when doctors start anti-TB treatment in people who have new fluid around the lungs. TBP means TB infection affecting the lining around the lungs, causing fluid buildup. The study asks doctors about what tests they have access to, how they interpret pleural fluid tests and biomarkers, and what factors lead them to begin treatment when TB is suspected. It’s an observational survey, not a trial of a new treatment, and it doesn’t involve treating patients as part of the study.

To participate, you would need to be an adult (18+) respiratory physician practicing in the Asia-Pacific region, especially in areas with a higher TB burden, and you must consent to take part. The online questionnaire is designed for doctors and will take a short amount of time to complete; about 400 doctors are being invited. No patient data or procedures are involved, and results will reflect doctors’ opinions and practices rather than patient information. The study is led by Ka Pang Chan at the Chinese University of Hong Kong, with the university as sponsor. Enrollment is ongoing by invitation, and the study is expected to conclude around February 2025.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Respiratory doctors practising in Asia-Pacific region
• Exclusion Criteria:
• • Do not consent for the study